The Patent Finder

Grifols Diagnostic Solutions Inc.

7 patents currently held · Updated Nov 17, 2026
3 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Apr 2037
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Jan 25, 2027
    The maintenance fee for Compositions, Methods And/Or Kits Comprising a Recombinant Human CD38-Extracellular Domain (US 11,708,418) comes due Jan 25, 2027. Unpaid by Jul 26, 2027, it lapses early.
  • 1 fee due Sep 5, 2027
    The maintenance fee for Immunoassays and Engineered Proteins for Monitoring Antibody Treatments to the Immune Checkpoint Inhibitors PD1 and PD-L1 (US 11,919,938) comes due Sep 5, 2027. Unpaid by Mar 6, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 2 of the patents on this record were granted since Aug 19, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 7 of 7

PatentTitleStatus Expires Confidence
US 11,169,160Device and Method for Detecting Blood Group Antigens by Means of an Incomplete Antibody
In force
 · High confidence
In forceHigh confidence
US 11,708,418Compositions, Methods And/Or Kits Comprising a Recombinant Human CD38-Extracellular Domain
In force
 · High confidence
In forceHigh confidence
US 11,242,571A Method to Homogenize Parvovirus B19 in Clinical Samples
In force
 · High confidence
In forceHigh confidence
US 11,919,938Immunoassays and Engineered Proteins for Monitoring Antibody Treatments to the Immune Checkpoint Inhibitors PD1 and PD-L1
In force
 · High confidence
In forceHigh confidence
US D1,152,002Machine Part
In force
 · High confidence
In forceHigh confidence
US 12,655,486Compositions and Methods for Detecting Plasmodium Species Nucleic Acid
In force
 · High confidence
In forceHigh confidence
US 12,747,285Anti-Human Immunodeficiency VIRUS-1 Antibodies and Methods for Uses Thereof
In force
 · High confidence
In forceHigh confidence
Also on record, not counted in the 7: 3 patents in force now held by others · 1 lapsed for an unpaid fee · 2 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

7 pending · 8 abandoned

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited